Ubl Named Next PhRMA President and CEO

Article

Stephen J. Ubl to succeed John J. Castellani as the next president and chief executive officer of PhRMA.

The board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) on Sept. 25, 2015 named Stephen J. Ubl the next president and chief executive officer of the association. He succeeds John J. Castellani, who will be retiring at the end of the year.

Ubl joins PhRMA after more than 10 years as the president and CEO of the Advanced Medical Technology Association where he worked with patient advocacy organizations, providers, and public and private payers. He was a board member of the National Health Council.

Source: Pharmaceutical Research and Manufacturers of America (PhRMA)

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content